| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disease Models, Animal | 15 | 2019 | 980 | 0.900 |
Why?
|
| Short Bowel Syndrome | 2 | 2010 | 8 | 0.750 |
Why?
|
| Intestinal Mucosa | 2 | 2010 | 64 | 0.720 |
Why?
|
| Animals | 49 | 2019 | 7297 | 0.690 |
Why?
|
| Abdominal Wall | 1 | 2017 | 20 | 0.610 |
Why?
|
| Endometriosis | 1 | 2017 | 66 | 0.580 |
Why?
|
| Macaca mulatta | 1 | 2017 | 322 | 0.550 |
Why?
|
| Lung Neoplasms | 8 | 2012 | 384 | 0.460 |
Why?
|
| Intestines | 2 | 2010 | 54 | 0.440 |
Why?
|
| Mice | 28 | 2019 | 2368 | 0.430 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2010 | 25 | 0.420 |
Why?
|
| Fish Oils | 1 | 2010 | 34 | 0.380 |
Why?
|
| Antibodies, Viral | 6 | 2016 | 55 | 0.380 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 51 | 0.380 |
Why?
|
| Ileocecal Valve | 1 | 2010 | 1 | 0.370 |
Why?
|
| Jejunum | 1 | 2010 | 3 | 0.370 |
Why?
|
| Colon | 1 | 2010 | 56 | 0.350 |
Why?
|
| Adenoma | 2 | 2008 | 35 | 0.340 |
Why?
|
| Flagellin | 4 | 2016 | 19 | 0.330 |
Why?
|
| Prolactin | 1 | 2008 | 10 | 0.330 |
Why?
|
| Biofilms | 4 | 2012 | 24 | 0.320 |
Why?
|
| Haemophilus influenzae | 4 | 2012 | 13 | 0.300 |
Why?
|
| Bacterial Proteins | 4 | 2012 | 77 | 0.290 |
Why?
|
| Adenocarcinoma | 2 | 2008 | 301 | 0.280 |
Why?
|
| Haemophilus Infections | 3 | 2012 | 7 | 0.270 |
Why?
|
| Genes, ras | 5 | 2009 | 26 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 57 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 747 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2010 | 670 | 0.260 |
Why?
|
| Influenza Vaccines | 2 | 2016 | 78 | 0.250 |
Why?
|
| Intestinal Volvulus | 1 | 2004 | 1 | 0.250 |
Why?
|
| Primate Diseases | 1 | 2004 | 2 | 0.250 |
Why?
|
| Lung | 6 | 2014 | 233 | 0.250 |
Why?
|
| Rats | 7 | 2019 | 1604 | 0.240 |
Why?
|
| Respiratory Tract Infections | 3 | 2014 | 41 | 0.210 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2012 | 13 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 2 | 2015 | 51 | 0.210 |
Why?
|
| Doxorubicin | 2 | 2013 | 55 | 0.200 |
Why?
|
| Mammary Glands, Animal | 3 | 2014 | 46 | 0.200 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2013 | 62 | 0.200 |
Why?
|
| Immunoglobulin G | 4 | 2015 | 104 | 0.200 |
Why?
|
| Lipoproteins | 2 | 2013 | 82 | 0.190 |
Why?
|
| Nanotubes, Carbon | 2 | 2011 | 22 | 0.190 |
Why?
|
| Anastomosis, Surgical | 2 | 2010 | 49 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2011 | 27 | 0.190 |
Why?
|
| Diarrhea | 2 | 2010 | 56 | 0.180 |
Why?
|
| Bordetella bronchiseptica | 2 | 2010 | 3 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 30 | 0.180 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 87 | 0.170 |
Why?
|
| Vaccines, Inactivated | 2 | 2016 | 37 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2019 | 6 | 0.170 |
Why?
|
| Curcumin | 2 | 2009 | 7 | 0.170 |
Why?
|
| Amnion | 1 | 2019 | 36 | 0.170 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 25 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 20 | 0.170 |
Why?
|
| Hydrogels | 1 | 2019 | 103 | 0.170 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 107 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 871 | 0.160 |
Why?
|
| Energy Transfer | 1 | 2018 | 1 | 0.160 |
Why?
|
| Female | 17 | 2019 | 18164 | 0.160 |
Why?
|
| Microbial Viability | 3 | 2014 | 4 | 0.160 |
Why?
|
| Male | 13 | 2019 | 17807 | 0.160 |
Why?
|
| Wound Healing | 1 | 2019 | 182 | 0.160 |
Why?
|
| Melanoma | 1 | 2019 | 148 | 0.150 |
Why?
|
| Macaca fascicularis | 4 | 2016 | 389 | 0.150 |
Why?
|
| Neoplasms | 3 | 2016 | 610 | 0.150 |
Why?
|
| Bacteriuria | 1 | 2017 | 4 | 0.150 |
Why?
|
| Copper | 1 | 2017 | 11 | 0.150 |
Why?
|
| Otitis Media | 3 | 2012 | 21 | 0.150 |
Why?
|
| Urinary Tract | 1 | 2017 | 21 | 0.150 |
Why?
|
| Bordetella pertussis | 2 | 2014 | 6 | 0.150 |
Why?
|
| Chemokines | 1 | 2016 | 35 | 0.150 |
Why?
|
| Isoflavones | 2 | 2008 | 65 | 0.140 |
Why?
|
| Coordination Complexes | 1 | 2016 | 6 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 711 | 0.140 |
Why?
|
| Mutation | 3 | 2008 | 466 | 0.140 |
Why?
|
| Receptors, Opioid | 1 | 2016 | 38 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2016 | 143 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2016 | 183 | 0.140 |
Why?
|
| Imidazoles | 1 | 2016 | 104 | 0.140 |
Why?
|
| Spinal Cord | 1 | 2016 | 139 | 0.130 |
Why?
|
| Organ Size | 3 | 2013 | 196 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2016 | 111 | 0.130 |
Why?
|
| Influenza A virus | 1 | 2014 | 21 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 160 | 0.130 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 16 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2016 | 152 | 0.130 |
Why?
|
| Milk | 1 | 2014 | 11 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2011 | 9 | 0.120 |
Why?
|
| Whooping Cough | 2 | 2014 | 10 | 0.120 |
Why?
|
| Pseudomonas Infections | 2 | 2011 | 9 | 0.120 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2014 | 9 | 0.120 |
Why?
|
| Viral Vaccines | 2 | 2011 | 13 | 0.120 |
Why?
|
| Lactation | 1 | 2014 | 14 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2014 | 10 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2014 | 9 | 0.120 |
Why?
|
| Vaccination | 1 | 2015 | 123 | 0.120 |
Why?
|
| Ovarian Follicle | 2 | 2010 | 23 | 0.120 |
Why?
|
| Phytosterols | 1 | 2013 | 1 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2014 | 122 | 0.110 |
Why?
|
| Carcinogens | 2 | 2012 | 34 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 507 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2008 | 666 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2012 | 11 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2012 | 11 | 0.110 |
Why?
|
| Cyclohexenes | 2 | 2010 | 12 | 0.110 |
Why?
|
| Vinyl Compounds | 2 | 2010 | 8 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 60 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 8 | 0.110 |
Why?
|
| Ovary | 2 | 2010 | 54 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2010 | 454 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 34 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 2 | 2012 | 31 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 34 | 0.110 |
Why?
|
| Paramyxovirinae | 1 | 2011 | 2 | 0.100 |
Why?
|
| Phosphorylcholine | 2 | 2009 | 5 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2013 | 147 | 0.100 |
Why?
|
| Vaccinia | 1 | 2011 | 6 | 0.100 |
Why?
|
| Viral Envelope Proteins | 1 | 2011 | 15 | 0.100 |
Why?
|
| Vaccinia virus | 1 | 2011 | 15 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2013 | 159 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 142 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2011 | 12 | 0.100 |
Why?
|
| Kidney Medulla | 1 | 2011 | 29 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2014 | 425 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 97 | 0.100 |
Why?
|
| Humans | 16 | 2019 | 29093 | 0.100 |
Why?
|
| Sexual Development | 1 | 2010 | 3 | 0.100 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 42 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 2010 | 8 | 0.100 |
Why?
|
| Feces | 1 | 2010 | 29 | 0.100 |
Why?
|
| Soybean Proteins | 2 | 2008 | 64 | 0.100 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 8 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 18 | 0.100 |
Why?
|
| Cross Protection | 1 | 2010 | 1 | 0.090 |
Why?
|
| Electrochemotherapy | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pertussis Vaccine | 1 | 2010 | 2 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 249 | 0.090 |
Why?
|
| Hyperphagia | 1 | 2010 | 2 | 0.090 |
Why?
|
| alpha-Glucosidases | 1 | 2010 | 2 | 0.090 |
Why?
|
| Weaning | 1 | 2010 | 6 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2010 | 4 | 0.090 |
Why?
|
| Needles | 1 | 2010 | 28 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 48 | 0.090 |
Why?
|
| Contrast Media | 1 | 2010 | 123 | 0.090 |
Why?
|
| Heart | 1 | 2011 | 161 | 0.090 |
Why?
|
| Estrogens | 2 | 2008 | 162 | 0.090 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2009 | 1 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 546 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 136 | 0.090 |
Why?
|
| Pseudomonas Vaccines | 1 | 2009 | 1 | 0.090 |
Why?
|
| Nanomedicine | 1 | 2009 | 17 | 0.090 |
Why?
|
| Epitopes | 1 | 2009 | 21 | 0.090 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 24 | 0.090 |
Why?
|
| RNA | 1 | 2010 | 88 | 0.090 |
Why?
|
| Bordetella Infections | 1 | 2008 | 1 | 0.090 |
Why?
|
| Immunization, Passive | 1 | 2008 | 3 | 0.090 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2008 | 7 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 170 | 0.090 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 7 | 0.090 |
Why?
|
| Phototherapy | 1 | 2009 | 47 | 0.090 |
Why?
|
| Mucociliary Clearance | 1 | 2008 | 1 | 0.080 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 8 | 0.080 |
Why?
|
| Pulmonary Emphysema | 1 | 2008 | 8 | 0.080 |
Why?
|
| Food, Formulated | 1 | 2008 | 10 | 0.080 |
Why?
|
| Iron, Dietary | 1 | 2008 | 11 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 41 | 0.080 |
Why?
|
| Contraceptives, Oral | 1 | 2008 | 20 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 140 | 0.080 |
Why?
|
| Rhabdoviridae Infections | 1 | 2008 | 4 | 0.080 |
Why?
|
| Viral Structural Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 204 | 0.080 |
Why?
|
| Rubulavirus Infections | 1 | 2008 | 7 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2008 | 34 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 5 | 0.080 |
Why?
|
| Viral Matrix Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2008 | 42 | 0.080 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2008 | 42 | 0.080 |
Why?
|
| Rabbits | 1 | 2008 | 185 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2008 | 54 | 0.080 |
Why?
|
| Propiophenones | 1 | 2007 | 3 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1379 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2007 | 15 | 0.080 |
Why?
|
| Uterus | 2 | 2006 | 73 | 0.080 |
Why?
|
| Doxycycline | 4 | 2009 | 25 | 0.080 |
Why?
|
| Chinchilla | 3 | 2012 | 3 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 680 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 192 | 0.070 |
Why?
|
| Apoptosis | 1 | 2009 | 337 | 0.070 |
Why?
|
| Prenatal Injuries | 1 | 2006 | 3 | 0.070 |
Why?
|
| Virulence | 3 | 2012 | 19 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2016 | 276 | 0.070 |
Why?
|
| ras Proteins | 1 | 2006 | 8 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2016 | 514 | 0.070 |
Why?
|
| Hyperthermia, Induced | 1 | 2009 | 235 | 0.070 |
Why?
|
| Postmenopause | 2 | 2008 | 397 | 0.070 |
Why?
|
| Ferritins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2009 | 249 | 0.070 |
Why?
|
| Homeostasis | 1 | 2006 | 127 | 0.070 |
Why?
|
| Iron | 1 | 2006 | 113 | 0.070 |
Why?
|
| Antibodies, Bacterial | 3 | 2010 | 31 | 0.070 |
Why?
|
| Colony Count, Microbial | 3 | 2010 | 17 | 0.070 |
Why?
|
| Stress, Physiological | 2 | 2017 | 44 | 0.060 |
Why?
|
| Aging | 2 | 2009 | 881 | 0.060 |
Why?
|
| Cecum | 1 | 2004 | 9 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 1218 | 0.060 |
Why?
|
| Soybeans | 1 | 2004 | 25 | 0.060 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2004 | 125 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 353 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 1079 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2013 | 41 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2014 | 64 | 0.050 |
Why?
|
| Myocardium | 2 | 2013 | 170 | 0.050 |
Why?
|
| Spleen | 2 | 2013 | 82 | 0.050 |
Why?
|
| Neutralization Tests | 2 | 2011 | 12 | 0.050 |
Why?
|
| Lanthanoid Series Elements | 1 | 2019 | 2 | 0.040 |
Why?
|
| Alpha Particles | 1 | 2019 | 7 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 17 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2019 | 56 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 71 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 39 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 76 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 201 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2010 | 113 | 0.040 |
Why?
|
| Gold | 1 | 2018 | 15 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 199 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 248 | 0.040 |
Why?
|
| Polymers | 1 | 2018 | 59 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2009 | 77 | 0.040 |
Why?
|
| Liver | 2 | 2013 | 464 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2018 | 47 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Ions | 1 | 2017 | 11 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 126 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 641 | 0.040 |
Why?
|
| Primates | 1 | 2017 | 100 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2016 | 5 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 519 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Microglia | 1 | 2016 | 48 | 0.040 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2016 | 7 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 49 | 0.030 |
Why?
|
| Phenotype | 2 | 2008 | 629 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2014 | 39 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 114 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2014 | 1 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 2001 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2013 | 2 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2013 | 6 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 494 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 2012 | 4 | 0.030 |
Why?
|
| Nitrosamines | 1 | 2012 | 10 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2013 | 43 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 598 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 5 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2012 | 2 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 14 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 246 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2012 | 34 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 64 | 0.030 |
Why?
|
| Weight Gain | 1 | 2013 | 108 | 0.030 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 5 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 17 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2011 | 18 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 666 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 53 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2011 | 60 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 2011 | 1 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2011 | 12 | 0.030 |
Why?
|
| Platelet Count | 1 | 2011 | 21 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 17 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2011 | 11 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2011 | 3 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2011 | 17 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 969 | 0.030 |
Why?
|
| Thrombosis | 1 | 2011 | 60 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 229 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 18 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 91 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 354 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 223 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 61 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2010 | 3 | 0.020 |
Why?
|
| Baroreflex | 1 | 2011 | 84 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 9 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 11 | 0.020 |
Why?
|
| Electrodes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Respiratory System | 1 | 2010 | 12 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 30 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 481 | 0.020 |
Why?
|
| Microscopy | 1 | 2010 | 27 | 0.020 |
Why?
|
| Homoserine | 1 | 2009 | 1 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 6 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 369 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2009 | 18 | 0.020 |
Why?
|
| Lactones | 1 | 2009 | 11 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sulindac | 1 | 2009 | 1 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2011 | 182 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 55 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 28 | 0.020 |
Why?
|
| Complement C3 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2011 | 279 | 0.020 |
Why?
|
| Myositis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 15 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 42 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2009 | 26 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 315 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2009 | 62 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 194 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 23 | 0.020 |
Why?
|
| Hematocrit | 1 | 2008 | 23 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2008 | 14 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 97 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 34 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2008 | 42 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 32 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2008 | 19 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 93 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2008 | 29 | 0.020 |
Why?
|
| Ferrets | 1 | 2008 | 19 | 0.020 |
Why?
|
| Interferons | 1 | 2008 | 17 | 0.020 |
Why?
|
| Nose | 1 | 2008 | 12 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 23 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 158 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 45 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3099 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2008 | 30 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 427 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 213 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 787 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 67 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 3 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 41 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2007 | 4 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 5 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 118 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 278 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 15 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 68 | 0.020 |
Why?
|
| Zebrafish | 1 | 2007 | 24 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 103 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 169 | 0.020 |
Why?
|
| Endometrium | 1 | 2008 | 120 | 0.020 |
Why?
|
| DNA Repair | 1 | 2007 | 50 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 426 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 248 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 290 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 200 | 0.020 |
Why?
|
| Methylcholanthrene | 1 | 2006 | 5 | 0.020 |
Why?
|
| Inbreeding | 1 | 2006 | 6 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 15 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 804 | 0.020 |
Why?
|
| Fetal Development | 1 | 2006 | 25 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 20 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 87 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2006 | 20 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 58 | 0.020 |
Why?
|
| Hela Cells | 1 | 2006 | 78 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2006 | 69 | 0.020 |
Why?
|
| Glioma | 1 | 2007 | 133 | 0.020 |
Why?
|
| Fetus | 1 | 2006 | 78 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 799 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 240 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 525 | 0.020 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 6 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2005 | 19 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 37 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2005 | 38 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 285 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 44 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 36 | 0.020 |
Why?
|
| Bronchi | 1 | 2005 | 41 | 0.020 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2005 | 44 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 158 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 72 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 208 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 172 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2005 | 225 | 0.020 |
Why?
|
| Alleles | 1 | 2005 | 251 | 0.020 |
Why?
|
| Gene Expression | 1 | 2006 | 332 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 7 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 28 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2004 | 147 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 485 | 0.010 |
Why?
|
| Brain | 1 | 2008 | 930 | 0.010 |
Why?
|